We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.
Jingyuan Qian, MPP
Advertisement
Articles by Jingyuan Qian, MPP
Advertisement
Latest Updated Articles
- Value-Based Arrangements May Be More Prevalent Than Assumed
February 13th 2019
Advertisement
Advertisement
Trending on AJMC
1
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
2
INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD
3
AI Reshaping Diabetes Care From Nutrition to Clinical Decisions
4
Social Factors Shape Diabetes, Dementia Risk Across Populations
5